Sergio Santillana will become Merrimack Pharmaceuticals Inc.'s chief medical officer on June 12.
Santillana is the former chief medical officer at ARIAD Pharmaceuticals.
Merrimack names chief medical officer
Identifying PPE Suppliers During the Pandemic
Highlighting the Top Regional Aftermarket Research Brokers by Sector Coverage
COVID-19 Impact & Recovery: Healthcare Outlook for H2 2021
Corporate Credit Risk Trends in Developing Markets: A Loss Given Default (LGD) Perspective
Merrimack names chief medical officer
- Author Ephraim Bie
- Theme Healthcare & Pharmaceuticals
- Author
- Ephraim Bie
- Theme
- Healthcare & Pharmaceuticals